UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Hematology, 2017-12, Vol.2017 (1), p.565-577

Ferreri, Andrés José María

2017

Volltextzugriff (PDF)

Primary central nervous system marginal zone lymphoma

British journal of haematology, 2024-01, Vol.204 (1), p.31-44

2024

Volltextzugriff (PDF)

Current uses of radiation therapy in patients with primary CNS lymphoma

Expert review of anticancer therapy, 2013-11, Vol.13 (11), p.1327-1337

2013

Volltextzugriff (PDF)

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Frontiers in oncology, 2021-11, Vol.11, p.730194-730194

2021

Volltextzugriff (PDF)

Consolidation Radiotherapy in Primary Central Nervous System Lymphomas: Impact on Outcome of Different Fields and Doses in Patients in Complete Remission After Upfront Chemotherapy

International journal of radiation oncology, biology, physics, 2011-05, Vol.80 (1), p.169-175

2011

Volltextzugriff (PDF)

Using immunogenetics to inform immunotherapy of lymphoid malignancies

The Lancet. Haematology, 2022-02, Vol.9 (2), p.e88-e89

2022

Volltextzugriff (PDF)

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Blood, 2024-04, Vol.143 (17), p.1713-1725

2024

Volltextzugriff (PDF)

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

HemaSphere, 2023-08, Vol.7 (S3), p.e91359ec-n/a

2023

Volltextzugriff (PDF)

Seeking solutions to old problems in elderly patients with lymphoma

The Lancet. Haematology, 2018-06, Vol.5 (6), p.e235-e236

María Ferreri, Andrés José

2018

Volltextzugriff (PDF)

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Blood advances, 2022-01, Vol.6 (1), p.327-338

2022

Volltextzugriff (PDF)

Salvage Therapy With Temozolomide in an Immunocompetent Patient With Primary Brain Lymphoma

JNCI : Journal of the National Cancer Institute, 2000-04, Vol.92 (7), p.575-576

2000

Volltextzugriff (PDF)

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type

Current research in translational medicine, 2021-10, Vol.69 (4), p.103313-103313, Article 103313

2021

Volltextzugriff (PDF)

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Blood advances, 2023-08, Vol.7 (16), p.4435-4447

2023

Volltextzugriff (PDF)

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

HemaSphere, 2023-08, Vol.7 (S3), p.e2454568-n/a

2023

Volltextzugriff (PDF)

Therapeutic management of refractory or relapsed primary central nervous system lymphomas

Annals of hematology, 2001-11, Vol.80 Suppl 3 (S3), p.B113-B118

2001

Volltextzugriff (PDF)

Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation

International journal of radiation oncology, biology, physics, 2002-02, Vol.52 (2), p.483-488

2002

Volltextzugriff (PDF)

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2001-11, Vol.34 (2), p.279-287

2001

Volltextzugriff (PDF)

Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B‐Cell Lymphoma

The oncologist (Dayton, Ohio), 2012-06, Vol.17 (6), p.838-846

2012

Volltextzugriff (PDF)

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3143-3143

2023

Volltextzugriff (PDF)

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

Hematological oncology, 2022-12, Vol.40 (5), p.846-856

2022

Volltextzugriff (PDF)

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (3), p.651-658

2001

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(26)
Hematology
(17)
Oncology
(14)
Adult
(12)
Aged
(12)
Male
(12)
Female
(11)
Middle Aged
(11)
Treatment Outcome
(10)
Lymphoma
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Biological And Medical Sciences
(5)
Central Nervous System Neoplasms - Radiotherapy
(5)
Combined Modality Therapy
(5)
Medical Sciences
(5)
Prognosis
(5)
Retrospective Studies
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Primary central nervous system marginal zone lymphoma

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Current uses of radiation therapy in patients with primary CNS lymphoma

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Consolidation Radiotherapy in Primary Central Nervous System Lymphomas: Impact on Outcome of Different Fields and Doses in Patients in Complete Remission After Upfront Chemotherapy

Using immunogenetics to inform immunotherapy of lymphoid malignancies

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

Seeking solutions to old problems in elderly patients with lymphoma

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Salvage Therapy With Temozolomide in an Immunocompetent Patient With Primary Brain Lymphoma

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

S221: LONG‐TERM RESULTS OF THE FIL MCL0208 TRIAL COMPARING LENALIDOMIDE MAINTENANCE (LEN) VS OBSERVATION (OBS) AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MANTLE CELL LYMPHOMA (MCL)

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

Therapeutic management of refractory or relapsed primary central nervous system lymphomas

Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma

Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B‐Cell Lymphoma

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

Suchergebnisse filtern